ruxolitinib,selinexor
novartis,incyte,karyopharm
['ruxolitinib', 'rux,(-crux),(-trux),(-deruxtecan)', '#mpn', 'selinexor', 'mpnsm']
significant reduction in spleen volume, total symptom score and hemoglobin stabilization was achieved with the combination of selinexor and ruxolitinib in a phase 1 study of patients with treatment-na ve myelofibrosis. #ash22 #mpnsm | 
Oncology news and insights from leading researchers and cancer centers.